Uterine Artery Embolization and Pelvic Floor Symptoms

The University of Texas System (UT)

Status: Withdrawn

Conditions: Leiomyoma; Prolapse; Incontinence

Study type: Observational

Funder types: Other

Identifiers

NCT00827645

112008-033

Details and patient eligibility

About

The objective of this study is to determine whether women who are already receiving treatment for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual dysfunction as well.

Sex: Female

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• female
• age 18-80 years
• symptomatic uterine fibroids
• scheduled for UAE
• Negative urine dipstick (negative result = trace or less for leukocytes & nitrites) or negative UA or negative culture (Urine dipstick is performed as standard of care)
• Available for 12-months of follow-up and able to complete study assessments, per clinician judgment
• Signed consent form

Exclusion criteria

• Age <18 or >80 years
• women who are unable to read and write English,
• pregnancy or planned pregnancy in the next 12 months
• < 6 months postpartum
• current use of anticholinergic medication, cholinergic agonists, tricyclic antidepressants, or duloxetine - must have been off such drugs for at least 4 weeks
• women with surgery for urinary incontinence or pelvic organ prolapse in the past 6 months
• history of bladder or pelvic cancer or pelvic radiation therapy
• prior augmentation cystoplasty
• urethral diverticulum, current or repaired.

Trial design

0 participants in 1 patient group

Uterine artery embolization

Description:

Women with symptomatic uterine fibroids scheduled for uterine artery embolization